Rx-360 would like to welcome our newest manufacturer member Novo Nordisk. We asked several questions to better understand their position within the supply chain and the expectations they have of the consortium. We are happy to have Novo Nordisk as a collaborative member of Rx-360 in our mission to protect patient safety by sharing information and developing processes to improve the integrity of the healthcare supply chain. As always, you can contact Novo Nordisk and all member organizations through our Member Directory. Welcome to the consortium we look forward to working with you.
Can you tell us a little about your company or organization?
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs approximately 42,100 people in 79 countries and markets its products in more than 170 countries. For more information, visit novonordisk.com, Facebook, Twitter, LinkedIn, YouTube.
What led you to join Rx-360?
We would like to see if Rx-360 can be used as add on to our own supplier audits.
How do you see the joint audit program supporting your organization?
The Rx-360 joint audit program will add on to our own supplier audits.